权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

C3 Mitigates Epithelial Injury in Pneumonia

C3 减轻肺炎中的上皮损伤

基本信息

批准号：
9806544
负责人：
Hrishikesh Satish Kulkarni
金额：
$ 16.14万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9806544
关键词：
Address Advisory Committees Albumins Anti-Bacterial Agents Antibiotics Attenuated Award Bacteremia Bacteria Bacterial Pneumonia Binding Caspase Cause of Death Cell Death Cell Line Cell Survival Cells Cellular Stress Cellular Stress Response Cellular biology Cessation of life Cleaved cell Clustered Regularly Interspaced Short Palindromic Repeats Complement Complement 3a Complement 3b Critical Care Data Development Plans Environment Epithelial Epithelial Cells Epithelium Extracellular Space Extrahepatic Extramural Activities FRAP1 gene Faculty Fellowship Functional disorder Future Generations Genetic Goals Histology Hospitalization Host Defense Human Immune Immune response Immunophenotyping In Vitro Incubated Infection Infection Control Inflammation Inflammatory Injury Innate Immune Response Innovative Therapy Kinetics Knockout Mice Knowledge Lead Liquid substance Liver Cirrhosis LoxP-flanked allele Lung Lung Transplantation Lung diseases MAPK3 gene Manuscripts Master of Science Measures Mediating Medicine Mentors Mentorship Mission Molecular Biology Molecular Immunology Molecular Target Morbidity - disease rate Mus National Heart, Lung, and Blood Institute Natural Immunity Outcome Oxidative Stress Pathway interactions Patients Peptide Hydrolases Pharmacology Phase Physicians Plasma Play Pneumonia Pre-Clinical Model Principal Investigator Production Proteins Pseudomonas Publishing Research Research Personnel Resources Role Scientist Serum Severities Site Source Stress Surface Techniques Testing Therapeutic Training United States Universities Vascular Permeabilities Washington Wild Type Mouse authority career career development cell type clinical investigation cobra venom factor complement C3 precursor complement system cytokine design experience fighting improved in vivo injury and repair lung injury medical schools member mortality mortality risk mouse model novel programs receptor response skills stressor therapeutic candidate tool transcriptome sequencing transplant model uptake working group

项目摘要

PROJECT ABSTRACT This K08 proposal will expedite the principal investigator’s progress towards his goal of becoming an independent physician-scientist focused on developing innovative therapies to improve pneumonia outcomes. Candidate: The PI is a physician-scientist at Washington University School of Medicine (WUSM). He completed a fellowship in Pulmonary and Critical Care Medicine and obtained a Master of Science in Clinical Investigation from WUSM, developing expertise at the intersection of innate immunity and airway epithelial cell biology under the mentorship of Dr. John Atkinson, a world authority on the complement system. Under Dr. Atkinson’s mentorship, the PI investigated how intracellular proteins (specifically, complement component C3) modulate cellular responses by mitigating stress-induced cell death. He will leverage the skills gained during his fellowship to further analyze C3 as a cytoprotective therapeutic for reducing pneumonia severity, a major unmet need. Career Development Plan: The PI will execute this proposal under his primary mentor, Dr. Atkinson and co- mentors, Dr. Brody (an expert in airway epithelial cell biology) and Dr. Gelman (an expert in mouse models of lung injury) along with a team of intramural and extramural advisors from diverse fields. All members of the advisory team have considerable experience in nurturing independent investigators. WUSM provides a high- quality environment with excellent facilities, resources and opportunities, as well as a collaborative faculty. This 5-year plan builds on the PI’s prior experience and fills in the gaps in his training, providing him with the tools needed for independence. It includes the following objectives: (1) Master techniques in advanced molecular biology and immunology (i.e., immunophenotyping of mice); (2) Become familiar with designing innovative therapies to improve pneumonia outcomes using preclinical models of lung injury; (3) Present research regularly in diverse venues, actively participate in working groups and collaborate; (4) Enhance mentoring skills; and (5) Publish at least 1 manuscript per year directly related to this proposal. Research Plan: The scientific premise of the proposal is that intracellular C3 in the lung plays a critical protective role in pneumonia, which the PI will test via two Specific Aims. Aim 1 will investigate how C3 promotes airway epithelial cell survival during inflammatory stress in vitro. Aim 2 will interrogate how locally functioning C3 in the lung reduces bacterial pneumonia severity in vivo. The plan is a vehicle for the PI to become facile in: (1) modulating intracellular pathways important for epithelial cell survival; (2) analyzing newly developed conditional knockout mice to ascertain the predominant sources of proteins in the lungs; and (3) developing approaches to deliver or enhance the production of these proteins locally to alleviate lung disease. Completing the Aims will provide the PI with the skills that are readily applicable to other forms of lung injury, and epithelial dysfunction at other barrier surfaces. In short, this K08 award will bolster his scientific career as he becomes an independent investigator who will focus on reducing the burden of pulmonary diseases, in alignment with the NHLBI mission.

项目摘要